Comments on U.S. Drug Importation Proposal

Published on March 2, 2020

This submission outlines Vital’s concerns with the proposed U.S. drug importation framework, highlighting risks related to limited Canadian supply, regulatory gaps, and patient safety. It emphasizes the potential for increased shortages, system strain, and the need to protect Canada’s domestic drug supply.